Search
Adaptive Biotechnologies Corp
ADPTAdd to Watchlist
17.530USD
+0.750+4.47%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
2.80BMarket Cap
LossP/E TTM
Adaptive Biotechnologies Corp's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Adaptive Biotechnologies Corp is 9.64, ranking 19 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -54.63, which is -97.12% below the recent high of -1.57 and -6.85% above the recent low of -58.37.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
